How to buy Alimera Sciences stock (ALIM)

Alimera Sciences is a drug manufacturers - specialty & generic business based in the US. Alimera Sciences shares (ALIM) are listed on the NASDAQ and all prices are listed in US Dollars. Alimera Sciences employs 154 staff and has a trailing 12-month revenue of around $99.7 million.

Our top picks for where to buy Alimera Sciences stock

Buy Alimera Sciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Alimera Sciences stock price (NASDAQ: ALIM)

Use our graph to track the performance of ALIM stocks over time.

Alimera Sciences shares at a glance

• Key figures

Information last updated 2024-11-10.

52-week range	$2.77 - $5.65
50-day moving average more info button	$5.56
200-day moving average more info button	$4.23
Wall St. target price	$5.67
PE ratio more info button	5.2762
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$1.05

Is it a good time to buy Alimera Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Alimera Sciences stock undervalued or overvalued?

Valuing Alimera Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alimera Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Alimera Sciences's P/E ratio

Alimera Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Alimera Sciences shares trade at around 5x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Alimera Sciences's EBITDA

Alimera Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.8 million.

The EBITDA is a measure of a Alimera Sciences's overall financial performance and is widely used to measure a its profitability.

Alimera Sciences financials

Revenue TTM	$99.7 million
Operating margin TTM	7.86%
Gross profit TTM	$52 million
Return on assets TTM	0.98%
Return on equity TTM	-34.57%
Profit margin	-14.74%
Book value	$0.74
Market Capitalization more info button	$301.3 million

TTM: trailing 12 months

Alimera Sciences share dividends

We're not expecting Alimera Sciences to pay a dividend over the next 12 months.

Have Alimera Sciences's shares ever split?

Alimera Sciences's shares were split on a 1:15 basis on 14 November 2019 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Alimera Sciences shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Alimera Sciences shares which in turn could have impacted Alimera Sciences's share price.

Alimera Sciences share price volatility

Over the last 12 months, Alimera Sciences's shares have ranged in value from as little as $2.77 up to $5.65. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alimera Sciences's is 1.245. This would suggest that Alimera Sciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Alimera Sciences overview

Alimera Sciences, Inc. , a pharmaceutical company, develops and commercializes prescription ophthalmic retinal pharmaceuticals. It operates through United States, International, and Operating Cost segments. The company offers ILUVIEN, a fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). It also provides YUTIQ, a fluocinolone acetonide intravitreal implant to treat NIU-PS. The company sells its products to physician offices, clinics, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc.

Frequently asked questions

null
What percentage of Alimera Sciences is owned by insiders or institutions?
Currently 5.345% of Alimera Sciences shares are held by insiders and 86.54% by institutions. How many people work for Alimera Sciences?
Latest data suggests 154 work at Alimera Sciences. When does the fiscal year end for Alimera Sciences?
Alimera Sciences's fiscal year ends in December. Where is Alimera Sciences based?
Alimera Sciences's address is: 6310 Town Square, Alpharetta, GA, United States, 30005 What is Alimera Sciences's ISIN number?
Alimera Sciences's international securities identification number is: US0162592028 What is Alimera Sciences's CUSIP number?
Alimera Sciences's Committee on Uniform Securities Identification Procedures number is: 016259202